share_log

Landfar Bio-medicine Co., Ltd's (SZSE:000504) Last Week's 11% Decline Must Have Disappointed Retail Investors Who Have a Significant Stake

Landfar Bio-medicine Co., Ltd's (SZSE:000504) Last Week's 11% Decline Must Have Disappointed Retail Investors Who Have a Significant Stake

Landfar Bio-Medicine Co., Ltd(深交所代码:000504)上周下跌11%,一定让持有大量股份的散户投资者失望
Simply Wall St ·  2023/05/08 21:12

Key Insights

主要见解

  • The considerable ownership by retail investors in Landfar Bio-medicine indicates that they collectively have a greater say in management and business strategy
  • A total of 5 investors have a majority stake in the company with 50% ownership
  • Ownership research, combined with past performance data can help provide a good understanding of opportunities in a stock
  • 散户投资者对兰德法尔生物医药公司的大量持股表明,他们在管理和商业战略方面拥有更大的发言权
  • 共有5名投资者持有该公司50%的多数股权
  • 所有权研究,结合过去的业绩数据,可以帮助您更好地了解股票的机会

A look at the shareholders of Landfar Bio-medicine Co., Ltd (SZSE:000504) can tell us which group is most powerful. The group holding the most number of shares in the company, around 42% to be precise, is retail investors. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

看看兰德法尔生物医药股份有限公司(深交所股票代码:000504)的股东,我们就知道哪个集团最有实力。持有该公司股份最多的群体,准确地说约为42%,是散户投资者。换句话说,该集团将从他们对公司的投资中获得最大(或损失最大)。

As a result, retail investors as a group endured the highest losses last week after market cap fell by CN¥430m.

其结果是,在市值缩水4.3亿元人民币后,散户投资者作为一个整体上周遭受了最大的损失。

Let's delve deeper into each type of owner of Landfar Bio-medicine, beginning with the chart below.

让我们从下面的图表开始,更深入地研究兰德法尔生物医药的每一种类型的所有者。

See our latest analysis for Landfar Bio-medicine

查看我们对兰德法尔生物医学的最新分析

ownership-breakdown
SZSE:000504 Ownership Breakdown May 9th 2023
深交所:000504所有权明细2023年5月9日

What Does The Institutional Ownership Tell Us About Landfar Bio-medicine?

关于兰德法尔生物医药,机构所有权告诉了我们什么?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

机构通常在向自己的投资者报告时,以基准来衡量自己,因此一旦一只股票被纳入主要指数,它们往往会对这只股票变得更加热情。我们预计,大多数公司都会有一些机构登记在册,特别是在它们正在增长的情况下。

Landfar Bio-medicine already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Landfar Bio-medicine, (below). Of course, keep in mind that there are other factors to consider, too.

兰德法尔生物医药公司已经在股票登记处登记了机构。事实上,他们在该公司拥有可观的股份。这可以表明该公司在投资界具有一定的公信力。然而,最好警惕依赖机构投资者带来的所谓验证。他们也一样,有时也会犯错。如果两个大型机构投资者试图同时抛售一只股票,股价大幅下跌的情况并不少见。因此,查看兰德法尔生物医药过去的盈利轨迹是值得的(见下图)。当然,请记住,还有其他因素需要考虑。

earnings-and-revenue-growth
SZSE:000504 Earnings and Revenue Growth May 9th 2023
深交所:2023年5月9日盈利和收入增长000504

Landfar Bio-medicine is not owned by hedge funds. Hunan Caixin Venture Capital Co. Ltd is currently the largest shareholder, with 26% of shares outstanding. For context, the second largest shareholder holds about 11% of the shares outstanding, followed by an ownership of 5.0% by the third-largest shareholder.

兰德法尔生物医药公司并非由对冲基金所有。湖南财新创业投资有限公司是目前的第一大股东,持有26%的流通股。作为参考,第二大股东持有约11%的流通股,第三大股东持有5.0%的股份。

To make our study more interesting, we found that the top 5 shareholders control more than half of the company which implies that this group has considerable sway over the company's decision-making.

为了让我们的研究更有趣,我们发现,前5名股东控制着公司一半以上的股份,这意味着这一群体对公司的决策具有相当大的影响力。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.

虽然研究一家公司的机构持股可以增加你的研究价值,但研究分析师的建议以更深入地了解一只股票的预期表现也是一个很好的做法。我们的信息显示,分析师没有对该股进行任何报道,因此它可能鲜为人知。

Insider Ownership Of Landfar Bio-medicine

兰德法尔生物医药的内部所有权

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

公司内部人的定义可能是主观的,而且在不同的司法管辖区之间确实有所不同。我们的数据反映了个别内部人士,至少捕捉到了董事会成员。管理层最终要向董事会负责。然而,经理人担任执行董事会成员并不少见,尤其是如果他们是创始人或首席执行官的话。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常认为内部人持股是一件好事。然而,在某些情况下,这会让其他股东更难让董事会对决策负责。

We can see that insiders own shares in Landfar Bio-medicine Co., Ltd. It has a market capitalization of just CN¥3.4b, and insiders have CN¥91m worth of shares, in their own names. Some would say this shows alignment of interests between shareholders and the board. But it might be worth checking if those insiders have been selling.

我们可以看到,内部人持有兰德生物医药有限公司的股份,其市值仅为34亿元人民币,内部人士以自己的名义持有价值9100万元的股票。有人会说,这表明股东和董事会之间的利益一致。但或许值得一查的是,这些内部人士是否一直在抛售。

General Public Ownership

一般公有制

The general public, who are usually individual investors, hold a 42% stake in Landfar Bio-medicine. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

公众通常是个人投资者,他们持有兰德法尔生物医药公司42%的股份。尽管这种规模的所有权可能不足以影响有利于他们的政策决定,但他们仍然可以对公司政策产生集体影响。

Private Equity Ownership

私募股权所有权

With an ownership of 37%, private equity firms are in a position to play a role in shaping corporate strategy with a focus on value creation. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.

拥有37%股权的私募股权公司有能力在塑造专注于价值创造的公司战略方面发挥作用。一些人可能会喜欢这样,因为私人股本有时是让管理层承担责任的积极分子。但在其他时候,私募股权公司让公司上市后,它们的股票都卖光了。

Private Company Ownership

私营公司所有权

We can see that Private Companies own 13%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我们可以看到,私营公司拥有13%的已发行股份。仅从这一事实很难得出任何结论,因此值得调查一下谁拥有这些私营公司。有时,内部人士或其他关联方通过一家独立的私人公司拥有上市公司的股份。

Next Steps:

接下来的步骤:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.

我发现看看到底是谁拥有一家公司是非常有趣的。但为了真正获得洞察力,我们还需要考虑其他信息。

I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow, for free.

我喜欢潜入更深的地方了解一家公司过去的表现。您可以访问此互动图过去的收益、收入和现金流,是免费的。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

当然了,如果你把目光投向别处,你可能会发现这是一笔很棒的投资。所以让我们来看看这个免费有趣的公司名单。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的数字是使用过去12个月的数据计算的,指的是截至财务报表日期的最后一个月的12个月期间。这可能与全年的年度报告数字不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发